Company’s mobile lab to visit 20 campuses across China, sharing protein research knowledge through live digital demonstrations Shanghai, China, June 20, 2019 — MilliporeSigma, a leading science and technology company, today announced a national campus tour in China for the company’s first mobile protein research laboratory. The retrofitted van, converted into a lab on wheels, is... Read more
Collaboration assures BGI’s and NRGene’s commitment to provide the most advanced technological breeding tools the Asian market June 6, 2019, Ness Ziona, Israel and Shenzhen, China BGI, the world’s largest omics organization, announced today that it will be offering NRGene’s technology as part of its broad genomics analysis services in agriculture research. BGI supports genomic... Read more
05 JUN 2019 | DARMSTADT, GERMANY Start-ups can apply for programs at company headquarters in Darmstadt or in China Focus is on four fields: biosensing & interfaces, liquid biopsy technologies, clean meat, and artificial intelligence (AI)-enabled health solutions Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that that it has opened the next... Read more
March 14, 2019 MilliporeSigma’s global network of more than 80 CRISPR core partners promote ethical scientific exploration with genome editing via access to company’s network of experts Zhejiang University is first in China to use MilliporeSigma’s Arrayed CRISPR Library MilliporeSigma, a leading science and technology company, today announced a CRISPR core partnership with Zhejiang University... Read more
From January 2019, startups from nine different countries will collaborate with Merck KGaA, Darmstadt Germany Selected teams will have the opportunity to extend their stay in the company’s China Innovation Hub in Shanghai For the first time, the program includes a startup specializing in the fight against multi-drug resistant bacteria Darmstadt, Germany, January 16, 2019... Read more
December 18, 2018 ~ Services and Capacity Increase with New Site Opening ~ (San Diego, Calif., December 13, 2018) — Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, has recently announced the expansion of its existing translational oncology research capacity by opening... Read more
Suzhou, China and Cambridge, UK, December 6: Abcam plc, a global innovator in life science reagents and tools, and QIAGEN (Suzhou) Translational Medicine Co., Ltd. (QIAGEN (Suzhou)) have signed a Memorandum of Understanding (MoU) agreement to jointly develop a pipeline of Companion Diagnostic (CDx) and In Vitro Diagnostic reagents and kits, to meet the specific needs... Read more
November 15, 2018 SHANGHAI, China, Nov. 15, 2018 – Honeywell today announced that William Yu has been appointed as President of Honeywell China. He will also continue to serve as Vice President and General Manager of Asia Pacific for Honeywell’s Performance Materials and Technologies (PMT) business. Yu joined Honeywell in January 2017. Under his leadership,... Read more
Xiamen, China, 13 November 2018 New hub integrates all of ABB’s activities in southeastern coastal city to create state-of-the-art campus specializing in advanced technologies US$300 million investment in the hub which is ABB’s largest innovation and manufacturing site at 425,000m2 Employs 3,500 people, covering the full range of business activities Strong symbol of ABB’s ongoing commitment... Read more
Merck KGaA, Darmstadt, Germany, today signed an agreement with the Guangzhou Development District on innovation development in Southern China. 12 NOV 2018 | DARMSTADT, GERMANY Company signed agreement with Guangzhou Development District Darmstadt, Germany, November 12, 2018 – Merck KGaA, Darmstadt, Germany, the vibrant science and technology company, today signed an agreement with the Guangzhou Development District... Read more